Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

50.42
+2.575.37%
Post-market: 50.470.0465+0.09%19:57 EDT
Volume:453.10K
Turnover:22.50M
Market Cap:3.60B
PE:-42.89
High:50.71
Open:47.47
Low:47.47
Close:47.85
52wk High:50.71
52wk Low:12.56
Shares:71.32M
Float Shares:20.81M
Volume Ratio:1.05
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1756
EPS(LYR):-1.0800
ROE:-78.49%
ROA:-44.34%
PB:36.14
PE(LYR):-46.69

Loading ...

Pulse Biosciences prioritizes R&D and clinical investment for its nPulse cardiac catheter pivotal IDE studies in the US and Europe

Reuters
·
Mar 17

Pulse Biosciences enrolls first patients in 30-person feasibility study of nPulse Vybrance system for papillary thyroid microcarcinoma

Reuters
·
Mar 12

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors With Npulse™ Technology

THOMSON REUTERS
·
Mar 12

Pulse Biosciences Earnings Call: Data Strength Vs. Cash Burn

TIPRANKS
·
Mar 10

Pulse Biosciences Reports Durable Thyroid Nodule Ablation Results

TIPRANKS
·
Mar 09

Pulse Biosciences Announces Clinical Data From Npulse™ Vybrance™ System First-in-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

THOMSON REUTERS
·
Mar 09

Pulse Biosciences to Present at Oppenheimer Annual Healthcare MedTech & Services Conference

Reuters
·
Mar 05

Pulse Biosciences to Showcase nPulse Vybrance System at North American Society for Interventional Thyroidology Annual Meeting

Reuters
·
Mar 04

Pulse Biosciences Highlights nPulse Cardiac Ablation Progress

TIPRANKS
·
Mar 04

Pulse Biosciences Files Amended 8-K to Remove Two Sentences

Reuters
·
Mar 02

Pulse Biosciences (PLSE) Is Down 12.6% After Wider Losses And New Funding Plans - Has The Bull Case Changed?

Simply Wall St.
·
Feb 28

Pulse Biosciences Announces Resignation of Chief Commercial Officer

TIPRANKS
·
Feb 28

Pulse Biosciences Chief Commercial Officer Kevin P. Danahy Resigns Immediately

Reuters
·
Feb 28

Pulse Biosciences Chief Commercial Officer Kevin Patrick Danahy Disposes of Common Shares

Reuters
·
Feb 24

Pulse Biosciences Grants 19,000 Inducement Stock Options to New Hires

Reuters
·
Feb 21

Stock Track | Pulse Biosciences Plummets 5.06% Intraday as Profit-Taking Follows Strong Quarterly Gains Despite Earnings Beat

Stock Track
·
Feb 20

Pulse Biosciences Inc. : Oppenheimer Raises Target Price to $30 From $22

THOMSON REUTERS
·
Feb 20

Mizuho Securities Sticks to Their Buy Rating for Pulse Biosciences (PLSE)

TIPRANKS
·
Feb 20

Pulse Biosciences to Present at TD Cowen Healthcare Conference

Reuters
·
Feb 20

BRIEF-Pulse Biosciences Says It Enters Equity Distribution Agreement With TD Securities

Reuters
·
Feb 20